The United States Centers for Disease Control and Prevention has data on drug overdose death rates and totals. Around 1,106,900 US residents died from drug overdoses from 1968 to 2020, around 932,400 from 1999 through 2020 and around 91,800 in 2020. Of every 100,000 people in 2020 in the US, drugs killed 28. Opioids were involved in around 80,400 of the around 106,700 deaths in 2021. Synthetic opioids other than methadone (primarily fentanyl) were involved with 70,601 deaths in 2021. [3] [4] [5]
Around 110,800 people died in 2022. Around 112,100 people died in the 12-month period ending August 31, 2023, at a rate of 307 deaths per day. That is 34 deaths per 100,000 US residents, using the population at the midpoint of that period. [6] [7]
The numbers at the source for the table below are continually updated. So the numbers in the table below may be slightly different. [3] 2021 was a turning point in US history with over 100,000 deaths. [9]
Year | Deaths | Population (July 1 residents) | Crude rate | Age adjusted rate |
---|---|---|---|---|
1968 | 5,033 | 199,533,564 | 2.5 | 2.8 |
1969 | 6,006 | 201,568,206 | 3.0 | 3.3 |
1970 | 7,101 | 203,458,035 | 3.5 | 3.8 |
1971 | 6,771 | 206,782,970 | 3.3 | 3.5 |
1972 | 6,622 | 209,237,411 | 3.2 | 3.4 |
1973 | 6,413 | 211,361,965 | 3.0 | 3.2 |
1974 | 6,449 | 213,436,958 | 3.0 | 3.2 |
1975 | 7,145 | 215,457,198 | 3.3 | 3.4 |
1976 | 6,765 | 217,615,788 | 3.1 | 3.2 |
1977 | 6,130 | 219,808,632 | 2.8 | 2.9 |
1978 | 5,506 | 222,102,279 | 2.5 | 2.6 |
1979 | 2,544 | 224,635,398 | 1.1 | 1.1 |
1980 | 2,492 | 226,624,371 | 1.1 | 1.1 |
1981 | 2,668 | 229,487,512 | 1.2 | 1.2 |
1982 | 2,862 | 231,701,425 | 1.2 | 1.2 |
1983 | 2,866 | 233,781,743 | 1.2 | 1.2 |
1984 | 3,266 | 235,922,142 | 1.4 | 1.3 |
1985 | 3,612 | 238,005,715 | 1.5 | 1.5 |
1986 | 4,187 | 240,189,882 | 1.7 | 1.7 |
1987 | 3,907 | 242,395,034 | 1.6 | 1.6 |
1988 | 4,865 | 244,651,961 | 2.0 | 2.0 |
1989 | 5,035 | 247,001,762 | 2.0 | 2.0 |
1990 | 4,506 | 248,922,111 | 1.8 | 1.8 |
1991 | 5,215 | 253,088,068 | 2.1 | 2.0 |
1992 | 5,951 | 256,606,463 | 2.3 | 2.3 |
1993 | 7,382 | 260,024,637 | 2.8 | 2.8 |
1994 | 7,828 | 263,241,475 | 3.0 | 3.0 |
1995 | 8,000 | 266,386,596 | 3.0 | 3.0 |
1996 | 8,431 | 269,540,779 | 3.1 | 3.1 |
1997 | 9,099 | 272,776,678 | 3.3 | 3.3 |
1998 | 9,838 | 276,032,848 | 3.6 | 3.6 |
1999 | 16,849 | 279,040,168 | 6.0 | 6.1 |
2000 | 17,415 | 281,421,906 | 6.2 | 6.2 |
2001 | 19,394 | 284,968,955 | 6.8 | 6.8 |
2002 | 23,518 | 287,625,193 | 8.2 | 8.2 |
2003 | 25,785 | 290,107,933 | 8.9 | 8.9 |
2004 | 27,424 | 292,805,298 | 9.4 | 9.4 |
2005 | 29,813 | 295,516,599 | 10.1 | 10.1 |
2006 | 34,425 | 298,379,912 | 11.5 | 11.5 |
2007 | 36,010 | 301,231,207 | 12.0 | 11.9 |
2008 | 36,450 | 304,093,966 | 12.0 | 11.9 |
2009 | 37,004 | 306,771,529 | 12.1 | 11.9 |
2010 | 38,329 | 308,745,538 | 12.4 | 12.3 |
2011 | 41,340 | 311,591,917 | 13.3 | 13.2 |
2012 | 41,502 | 313,914,040 | 13.2 | 13.1 |
2013 | 43,982 | 316,128,839 | 13.9 | 13.8 |
2014 | 47,055 | 318,857,056 | 14.8 | 14.7 |
2015 | 52,404 | 321,418,820 | 16.3 | 16.3 |
2016 | 63,632 | 323,127,513 | 19.7 | 19.8 |
2017 | 70,237 | 325,719,178 | 21.6 | 21.7 |
2018 | 67,367 | 327,167,434 | 20.6 | 20.7 |
2019 | 70,630 | 328,239,523 | 21.5 | 21.6 |
2020 | 91,799 | 329,484,123 | 27.9 | 28.3 |
Total | 1,106,859 |
Asterisks (*) indicate Health in STATE or Healthcare in STATE links in table below.
State | 1999 | 2005 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|---|---|---|---|
Alabama * | 3.9 | 6.3 | 15.2 | 15.7 | 16.2 | 18 | 16.6 | 16.3 | 22.3 | 30.1 |
Alaska * | 7.5 | 11.4 | 16.8 | 16 | 16.8 | 20.2 | 14.6 | 17.8 | 22 | 35.6 |
Arizona | 10.6 | 14.1 | 12.6 | 19 | 20.3 | 22.2 | 23.8 | 26.8 | 35.8 | 38.7 |
Arkansas * | 4.4 | 10.1 | 18.2 | 13.8 | 14 | 15.5 | 15.7 | 13.5 | 19.1 | 22.3 |
California * | 8.1 | 9 | 11.1 | 11.3 | 11.2 | 11.7 | 12.8 | 15 | 21.8 | 26.6 |
Colorado * | 8 | 12.7 | 16.3 | 15.4 | 16.6 | 17.6 | 16.8 | 18 | 24.9 | 31.4 |
Connecticut | 9 | 8.5 | 17.6 | 22.1 | 27.4 | 30.9 | 30.7 | 34.7 | 39.1 | 42.3 |
Delaware | 6.4 | 7.5 | 20.9 | 22 | 30.8 | 37 | 43.8 | 48 | 47.3 | 54 |
Florida * | 6.4 | 13.5 | 13.2 | 16.2 | 23.7 | 25.1 | 22.8 | 25.5 | 35 | 37.5 |
Georgia * | 3.5 | 8.2 | 11.9 | 12.7 | 13.3 | 14.7 | 13.2 | 13.1 | 18 | 23.5 |
Hawaii * | 6.5 | 9.4 | 10.9 | 11.3 | 12.8 | 13.8 | 14.3 | 15.9 | 18.3 | 17.3 |
Idaho * | 5.3 | 8.1 | 13.7 | 14.2 | 15.2 | 14.4 | 14.6 | 15.1 | 15.9 | 19 |
Illinois | 6.7 | 8.4 | 13.1 | 14.1 | 18.9 | 21.6 | 21.3 | 21.9 | 28.1 | 29 |
Indiana | 3.2 | 9.8 | 18.2 | 19.5 | 24 | 29.4 | 25.6 | 26.6 | 36.7 | 43 |
Iowa | 1.9 | 4.8 | 8.8 | 10.3 | 10.6 | 11.5 | 9.6 | 11.5 | 14.3 | 15.3 |
Kansas | 3.4 | 9.1 | 11.7 | 11.8 | 11.1 | 11.8 | 12.4 | 14.3 | 17.4 | 24.3 |
Kentucky | 4.9 | 15.3 | 24.7 | 29.9 | 33.5 | 37.2 | 30.9 | 32.5 | 49.2 | 55.6 |
Louisiana | 4.3 | 14.7 | 16.9 | 19 | 21.8 | 24.5 | 25.4 | 28.3 | 42.7 | 55.9 |
Maine | 5.3 | 12.4 | 16.8 | 21.2 | 28.7 | 34.4 | 27.9 | 29.9 | 39.7 | 47.1 |
Maryland * | 11.4 | 11.4 | 17.4 | 20.9 | 33.2 | 36.3 | 37.2 | 38.2 | 44.6 | 42.8 |
Massachusetts * | 7.5 | 12 | 19 | 25.7 | 33 | 31.8 | 32.8 | 32.1 | 33.9 | 36.8 |
Michigan | 4.6 | 9.8 | 18 | 20.4 | 24.4 | 27.8 | 26.6 | 24.4 | 28.6 | 31.5 |
Minnesota * | 2.8 | 5.4 | 9.6 | 10.6 | 12.5 | 13.3 | 11.5 | 14.2 | 19 | 24.5 |
Mississippi * | 3.2 | 8.8 | 11.6 | 12.3 | 12.1 | 12.2 | 10.8 | 13.6 | 21.1 | 28.4 |
Missouri | 5 | 10.7 | 18.2 | 17.9 | 23.6 | 23.4 | 27.5 | 26.9 | 32.1 | 36.5 |
Montana * | 4.6 | 10.1 | 12.4 | 13.8 | 11.7 | 11.7 | 12.2 | 14.1 | 15.6 | 19.5 |
Nebraska | 2.3 | 5 | 7.2 | 6.9 | 6.4 | 8.1 | 7.4 | 8.7 | 11.3 | 11.4 |
Nevada | 11.5 | 18.7 | 18.4 | 20.4 | 21.7 | 21.6 | 21.2 | 20.1 | 26 | 29.2 |
New Hampshire | 4.3 | 10.7 | 26.2 | 34.3 | 39 | 37 | 35.8 | 32 | 30.3 | 32.3 |
New Jersey | 6.5 | 9.4 | 14 | 16.3 | 23.2 | 30 | 33.1 | 31.7 | 32.1 | 32.4 |
New Mexico | 15 | 20.1 | 27.3 | 25.3 | 25.2 | 24.8 | 26.7 | 30.2 | 39 | 51.6 |
New York * | 5 | 4.8 | 11.3 | 13.6 | 18 | 19.4 | 18.4 | 18.2 | 25.4 | 28.7 |
North Carolina * | 4.6 | 11.4 | 13.8 | 15.8 | 19.7 | 24.1 | 22.4 | 22.3 | 30.9 | 39.2 |
North Dakota * | 0 | 0 | 6.3 | 8.6 | 10.6 | 9.2 | 10.2 | 11.4 | 15.6 | 17.2 |
Ohio * | 4.2 | 10.9 | 24.6 | 29.9 | 39.1 | 46.3 | 35.9 | 38.3 | 47.2 | 48.1 |
Oklahoma * | 5.4 | 13.8 | 20.3 | 19 | 21.5 | 20.1 | 18.4 | 16.7 | 19.4 | 24.4 |
Oregon * | 6.1 | 10.4 | 12.8 | 12 | 11.9 | 12.4 | 12.6 | 14 | 18.7 | 26.8 |
Pennsylvania | 8.1 | 13.2 | 21.9 | 26.3 | 37.9 | 44.3 | 36.1 | 35.6 | 42.4 | 43.2 |
Rhode Island | 5.5 | 14.3 | 23.4 | 28.2 | 30.8 | 31 | 30.1 | 29.5 | 38.2 | 41.7 |
South Carolina * | 3.7 | 9.9 | 14.4 | 15.7 | 18.1 | 20.5 | 22.6 | 22.7 | 34.9 | 42.8 |
South Dakota | 0 | 5.5 | 7.8 | 8.4 | 8.4 | 8.5 | 6.9 | 10.5 | 10.3 | 12.6 |
Tennessee | 6.1 | 14.5 | 19.5 | 22.2 | 24.5 | 26.6 | 27.5 | 31.2 | 45.6 | 56.6 |
Texas * | 5.4 | 8.5 | 9.7 | 9.4 | 10.1 | 10.5 | 10.4 | 10.8 | 14.1 | 16.8 |
Utah * | 10.6 | 19.3 | 22.4 | 23.4 | 22.4 | 22.3 | 21.2 | 18.9 | 20.5 | 21.1 |
Vermont * | 4.7 | 8.5 | 13.9 | 16.7 | 22.2 | 23.2 | 26.6 | 23.8 | 32.9 | 42.3 |
Virginia * | 5 | 7.5 | 11.7 | 12.4 | 16.7 | 17.9 | 17.1 | 18.3 | 26.6 | 30.5 |
Washington * | 9.3 | 13 | 13.3 | 14.7 | 14.5 | 15.2 | 14.8 | 15.8 | 22 | 28.1 |
West Virginia * | 4.1 | 10.5 | 35.5 | 41.5 | 52 | 57.8 | 51.5 | 52.8 | 81.4 | 90.9 |
Wisconsin | 4 | 9.3 | 15.1 | 15.5 | 19.3 | 21.2 | 19.2 | 21.1 | 27.7 | 31.6 |
Wyoming | 4.1 | 4.9 | 19.4 | 16.4 | 17.6 | 12.2 | 11.1 | 14.1 | 17.4 | 18.9 |
Overall US totals by year, followed by breakdown by state by year. [4]
States | 1999 | 2005 | 2014 | 2015 | 2016 |
---|---|---|---|---|---|
Deaths | 16,801 | 29,736 | 46,959 | 52,279 | 63,363 |
States | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|
Deaths | 69,927 | 67,113 | 70,319 | 91,375 | 106,249 |
State links below are "Category:Health in STATE" links. See overall category.
State | 1999 | 2005 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|---|---|---|---|
Alabama | 169 | 283 | 723 | 736 | 756 | 835 | 775 | 768 | 1,029 | 1,408 |
Alaska | 46 | 79 | 124 | 122 | 128 | 147 | 110 | 132 | 160 | 260 |
Arizona | 511 | 794 | 356 | 1,274 | 1,382 | 1,532 | 1,670 | 1,907 | 2,550 | 2,730 |
Arkansas | 113 | 269 | 1,211 | 392 | 401 | 446 | 444 | 388 | 546 | 637 |
California | 2,662 | 3,214 | 4,521 | 4,659 | 4,654 | 4,868 | 5,348 | 6,198 | 8,908 | 10,901 |
Colorado | 349 | 608 | 899 | 869 | 942 | 1,015 | 995 | 1,079 | 1,492 | 1,887 |
Connecticut | 310 | 295 | 623 | 800 | 971 | 1,072 | 1,069 | 1,214 | 1,371 | 1,552 |
Delaware | 50 | 62 | 189 | 198 | 282 | 338 | 401 | 435 | 444 | 513 |
Florida | 997 | 2,371 | 2,634 | 3,228 | 4,728 | 5,088 | 4,698 | 5,268 | 7,231 | 7,827 |
Georgia | 283 | 738 | 1,206 | 1,302 | 1,394 | 1,537 | 1,404 | 1,408 | 1,916 | 2,500 |
Hawaii | 80 | 126 | 157 | 169 | 191 | 203 | 213 | 242 | 274 | 269 |
Idaho | 64 | 109 | 212 | 218 | 243 | 236 | 250 | 265 | 287 | 354 |
Illinois | 825 | 1,067 | 1,705 | 1,835 | 2,411 | 2,778 | 2,722 | 2,790 | 3,549 | 3,762 |
Indiana | 191 | 610 | 1,172 | 1,245 | 1,526 | 1,852 | 1,629 | 1,699 | 2,321 | 2,811 |
Iowa | 53 | 141 | 264 | 309 | 314 | 341 | 287 | 352 | 432 | 475 |
Kansas | 89 | 241 | 332 | 329 | 313 | 333 | 345 | 403 | 490 | 680 |
Kentucky | 197 | 638 | 1,077 | 1,273 | 1,419 | 1,566 | 1,315 | 1,380 | 2,083 | 2,381 |
Louisiana | 188 | 661 | 777 | 861 | 996 | 1,108 | 1,140 | 1,267 | 1,896 | 2,463 |
Maine | 67 | 163 | 216 | 269 | 353 | 424 | 345 | 371 | 496 | 611 |
Maryland | 629 | 656 | 1,070 | 1,285 | 2,044 | 2,247 | 2,324 | 2,369 | 2,771 | 2,737 |
Massachusetts | 488 | 780 | 1,289 | 1,724 | 2,227 | 2,168 | 2,241 | 2,210 | 2,302 | 2,585 |
Michigan | 460 | 985 | 1,762 | 1,980 | 2,347 | 2,694 | 2,591 | 2,385 | 2,759 | 3,089 |
Minnesota | 136 | 282 | 517 | 581 | 672 | 733 | 636 | 792 | 1,050 | 1,356 |
Mississippi | 87 | 248 | 336 | 351 | 352 | 354 | 310 | 394 | 586 | 787 |
Missouri | 276 | 608 | 1,067 | 1,066 | 1,371 | 1,367 | 1,610 | 1,583 | 1,875 | 2,155 |
Montana | 41 | 96 | 125 | 138 | 119 | 119 | 125 | 143 | 162 | 199 |
Nebraska | 39 | 86 | 125 | 126 | 120 | 152 | 138 | 161 | 214 | 214 |
Nevada | 227 | 457 | 545 | 619 | 665 | 676 | 688 | 647 | 832 | 949 |
New Hampshire | 54 | 142 | 334 | 422 | 481 | 467 | 452 | 407 | 393 | 441 |
New Jersey | 557 | 823 | 1,253 | 1,454 | 2,056 | 2,685 | 2,900 | 2,805 | 2,840 | 3,056 |
New Mexico | 266 | 373 | 547 | 501 | 500 | 493 | 537 | 599 | 784 | 1,052 |
New York | 959 | 944 | 2,300 | 2,754 | 3,638 | 3,921 | 3,697 | 3,617 | 4,965 | 5,842 |
North Carolina | 366 | 1,000 | 1,358 | 1,567 | 1,956 | 2,414 | 2,259 | 2,266 | 3,146 | 3,981 |
North Dakota | 12 | 12 | 43 | 61 | 77 | 68 | 70 | 82 | 114 | 124 |
Ohio | 467 | 1,243 | 2,744 | 3,310 | 4,329 | 5,111 | 3,980 | 4,251 | 5,204 | 5,397 |
Oklahoma | 178 | 478 | 777 | 725 | 813 | 775 | 716 | 645 | 762 | 960 |
Oregon | 210 | 386 | 522 | 505 | 506 | 530 | 547 | 615 | 803 | 1,171 |
Pennsylvania | 990 | 1,613 | 2,732 | 3,264 | 4,627 | 5,388 | 4,415 | 4,377 | 5,168 | 5,449 |
Rhode Island | 58 | 156 | 247 | 310 | 326 | 320 | 317 | 307 | 397 | 455 |
South Carolina | 147 | 427 | 701 | 761 | 879 | 1,008 | 1,125 | 1,127 | 1,739 | 2,138 |
South Dakota | 17 | 40 | 63 | 65 | 69 | 73 | 57 | 86 | 83 | 105 |
Tennessee | 344 | 872 | 1,269 | 1,457 | 1,630 | 1,776 | 1,823 | 2,089 | 3,034 | 3,813 |
Texas | 1,087 | 1,910 | 2,601 | 2,588 | 2,831 | 2,989 | 3,005 | 3,136 | 4,172 | 4,984 |
Utah | 205 | 438 | 603 | 646 | 635 | 650 | 624 | 571 | 622 | 662 |
Vermont | 29 | 53 | 83 | 99 | 125 | 134 | 153 | 133 | 190 | 252 |
Virginia | 366 | 581 | 980 | 1,039 | 1,405 | 1,507 | 1,448 | 1,547 | 2,240 | 2,626 |
Washington | 555 | 850 | 979 | 1,094 | 1,102 | 1,169 | 1,164 | 1,259 | 1,733 | 2,264 |
West Virginia | 75 | 184 | 627 | 725 | 884 | 974 | 856 | 870 | 1,330 | 1,501 |
Wisconsin | 212 | 518 | 853 | 878 | 1,074 | 1,177 | 1,079 | 1,201 | 1,531 | 1,775 |
Wyoming | 20 | 26 | 109 | 96 | 99 | 69 | 66 | 79 | 99 | 109 |
Concerning the data in the charts below (in this section and the following sections) deaths from the various drugs add up to more than the yearly overdose death total because multiple drugs are involved in many of the deaths. [8]
Opioids were involved in around 80,400 of the around 106,700 deaths in 2021. [8] See map higher up for states with the highest overdose death rates.
There were around 68,700 drug overdose deaths in the United States in 2018. That is a rate of 210 deaths per million residents. [6] [7] Compare that rate to the 2018 rates of the European countries in the first chart below.
Location | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|
Austria | 235 | 191 | 196 | 184 | 154 |
Belgium | 168 | 152 | 148 | ||
Bulgaria | 20 | 24 | 11 | 24 | 18 |
Croatia | 77 | 99 | 97 | 85 | 65 |
Cyprus | 10 | 6 | 5 | 12 | 16 |
Czech Republic | 64 | 58 | 42 | 39 | 42 |
Denmark | 197 | 202 | 183 | 239 | |
Estonia | 39 | 33 | 27 | 39 | 110 |
Finland | 287 | 258 | 234 | 261 | 200 |
France | 417 | ||||
Germany | 1,826 | 1,581 | 1,398 | 1,276 | 1,272 |
Greece | 230 | 274 | 255 | ||
Hungary | 42 | 48 | 43 | 33 | 33 |
Ireland | 235 | ||||
Italy | 293 | 309 | 374 | 336 | 297 |
Latvia | 17 | 21 | 12 | 20 | 22 |
Lithuania | 62 | 47 | 52 | 59 | 83 |
Luxembourg | 5 | 6 | 8 | 4 | 8 |
Malta | 5 | 3 | 5 | ||
Netherlands | 298 | 295 | 252 | 224 | 262 |
Norway | 241 | 324 | 275 | 286 | 247 |
Poland | 229 | 212 | 199 | 202 | |
Portugal | 63 | 72 | 55 | 51 | |
Romania | 30 | 33 | 45 | 26 | 32 |
Slovakia | 28 | 37 | 34 | 32 | 19 |
Slovenia | 65 | 70 | 74 | 59 | 47 |
Spain | 774 | 546 | 450 | 437 | |
Sweden | 450 | 524 | 555 | 583 | 643 |
Turkey | 314 | 342 | 657 | 941 | |
United Kingdom | 3,284 |
The United States had an official estimated resident population of 334,914,895 on July 1, 2023, according to the U.S. Census Bureau. This figure includes the 50 states and the District of Columbia but excludes the population of five unincorporated U.S. territories as well as several minor island possessions. The United States is the third most populous country in the world. The Census Bureau showed a population increase of 0.4% for the twelve-month period ending in July 2022, below the world average annual rate of 0.9%. The total fertility rate in the United States estimated for 2022 is 1.665 children per woman, which is below the replacement fertility rate of approximately 2.1.
Substance abuse, also known as drug abuse, is the use of a drug in amounts or by methods that are harmful to the individual or others. It is a form of substance-related disorder. Differing definitions of drug abuse are used in public health, medical, and criminal justice contexts. In some cases, criminal or anti-social behavior occurs when the person is under the influence of a drug, and long-term personality changes in individuals may also occur. In addition to possible physical, social, and psychological harm, the use of some drugs may also lead to criminal penalties, although these vary widely depending on the local jurisdiction.
Fentanyl is a potent synthetic piperidine opioid primarily used as an analgesic. It is 50 times more potent than heroin and 100 times more potent than morphine; its primary clinical utility is in pain management for cancer patients and those recovering from painful surgeries. Fentanyl is also used as a sedative. Depending on the method of delivery, fentanyl can be very fast acting and ingesting a relatively small quantity can cause overdose. Fentanyl works by activating μ-opioid receptors. Fentanyl is sold under the brand names Actiq, Duragesic and Sublimaze, among others.
A drug overdose is the ingestion or application of a drug or other substance in quantities much greater than are recommended. Typically it is used for cases when a risk to health will potentially result. An overdose may result in a toxic state or death.
Opioid use disorder (OUD) is a substance use disorder characterized by cravings for opioids, continued use despite physical and/or psychological deterioration, increased tolerance with use, and withdrawal symptoms after discontinuing opioids. Opioid withdrawal symptoms include nausea, muscle aches, diarrhea, trouble sleeping, agitation, and a low mood. Addiction and dependence are important components of opioid use disorder.
Oxymorphone is a highly potent opioid analgesic indicated for treatment of severe pain. Pain relief after injection begins after about 5–10 minutes, after oral administration it begins after about 30 minutes, and lasts about 3–4 hours for immediate-release tablets and 12 hours for extended-release tablets. The elimination half-life of oxymorphone is much faster intravenously, and as such, the drug is most commonly used orally. Like oxycodone, which metabolizes to oxymorphone, oxymorphone has a high potential to be abused.
This is a list of US states by gun deaths and rates of violence. In 2021, there were 26,000 gun suicides and 21,000 gun homicides, together making up a sixth of deaths from external causes. Gun deaths make up about half of all suicides, but over 80% of homicides.
An opioid overdose is toxicity due to excessive consumption of opioids, such as morphine, codeine, heroin, fentanyl, tramadol, and methadone. This preventable pathology can be fatal if it leads to respiratory depression, a lethal condition that can cause hypoxia from slow and shallow breathing. Other symptoms include small pupils, and unconsciousness; however, its onset can depend on the method of ingestion, the dosage and individual risk factors. Although there were over 110,000 deaths in 2017 due to opioids, individuals who survived also faced adverse complications, including permanent brain damage.
Substance use disorder (SUD) is the persistent use of drugs despite the substantial harm and adverse consequences to one's own self and others, as a result of their use. In perspective, the effects of the wrong use of substances that are capable of causing harm to the user or others, have been extensively described in different studies using a variety of terms such as substance use problems, problematic drugs or alcohol use, and substance use disorder. The National Institute of Mental Health (NIMH) states that "Substance use disorder (SUD) is a treatable mental disorder that affects a person's brain and behavior, leading to their inability to control their use of substances like legal or illegal drugs, alcohol, or medications. Symptoms can be moderate to severe, with addiction being the most severe form of SUD". Substance use disorders (SUD) are considered to be a serious mental illness that fluctuates with the age that symptoms first start appearing in an individual, the time during which it exists and the type of substance that is used. It is not uncommon for those who have SUD to also have other mental health disorders. Substance use disorders are characterized by an array of mental/emotional, physical, and behavioral problems such as chronic guilt; an inability to reduce or stop consuming the substance(s) despite repeated attempts; operating vehicles while intoxicated; and physiological withdrawal symptoms. Drug classes that are commonly involved in SUD include: alcohol (alcoholism); cannabis; opioids; stimulants such as nicotine, cocaine and amphetamines; benzodiazepines; barbiturates; and other or unknown substances.
Acetylfentanyl is an opioid analgesic drug that is an analog of fentanyl. Studies have estimated acetylfentanyl to be 15 times more potent than morphine, which would mean that despite being somewhat weaker than fentanyl, it is nevertheless still several times stronger than pure heroin. It has never been licensed for medical use and instead has only been sold on the illicit drug market. Acetylfentanyl was discovered at the same time as fentanyl itself and had only rarely been encountered on the illicit market in the late 1980s. However, in 2013, Canadian police seized 3 kilograms of acetylfentanyl. As a μ-opioid receptor agonist, acetylfentanyl may serve as a direct substitute for oxycodone, heroin or other opioids. Common side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea and potentially fatal respiratory depression. Fentanyl analogs have killed hundreds of people throughout Europe and the former Soviet republics since the most recent resurgence in use began in Estonia in the early 2000s, and novel derivatives continue to appear.
There is an ongoing opioid epidemic in the United States, originating out of both medical prescriptions and illegal sources. The epidemic began in the United States in the late 1990s, according to the Centers for Disease Control and Prevention (CDC), when opioids were increasingly prescribed for pain management, resulting in a rise in overall opioid use throughout subsequent years.
A take-home naloxone program is a governmental program that provides naloxone drug kits to those that are at risk of an opioid overdose. Naloxone is a medication that was created to reverse opioid overdoses. As an opioid antagonist, it binds to the μ-opioid receptors blocking the opioid's effects. Naloxone quickly restores normal respiration. The ongoing opioid epidemic has caused many public health authorities to expand access to naloxone.
A disease of despair is one of three classes of behavior-related medical conditions that increase in groups of people who experience despair due to a sense that their long-term social and economic prospects are bleak. The three disease types are drug overdose, suicide, and alcoholic liver disease.
The opioid epidemic, also referred to as the opioid crisis, is the rapid increase in the overuse, misuse/abuse, and overdose deaths attributed either in part or in whole to the class of drugs called opiates/opioids since the 1990s. It includes the significant medical, social, psychological, demographic and economic consequences of the medical, non-medical, and recreational abuse of these medications.
This article contains the current number of confirmed COVID-19 deaths per population by country. It also has cumulative death totals by country. For these numbers over time see the tables, graphs, and maps at COVID-19 pandemic deaths and COVID-19 pandemic by country and territory.
Harm reduction consists of a series of strategies aimed at reducing the negative impacts of drug use on users. It has been described as an alternative to the U.S.'s moral model and disease model of drug use and addiction. While the moral model treats drug use as a morally wrong action and the disease model treats it as a biological or genetic disease needing medical intervention, harm reduction takes a public health approach with a basis in pragmatism. Harm reduction provides an alternative to complete abstinence as a method for preventing and mitigating the negative consequences of drug use and addiction.
New Jersey's most recent revised policy was issued September 7, 2022 pursuant to P.L.2021, c.152 which authorized opioid antidotes to be dispensed without a prescription or fee. Its goal is to make opioid antidotes widely available, reducing mortality from overdose while decreasing morbidity in conjunction with sterile needle access, fentanyl test strips, and substance use treatment programs. A $67 million grant provided by the Department of Health and Human Services provides funding for naloxone as well as recovery services. This policy enables any person to distribute an opioid antidote to someone they deem at risk of an opioid overdose, alongside information regarding: opioid overdose prevention and recognition, the administration of naloxone, circumstances that warrant calling 911 for assistance with an opioid overdose, and contraindications of naloxone. Instructions on how to perform resuscitation and the appropriate care of an overdose victim after the administration of an opioid antidote should also be included. Community first aid squads, professional organizations, police departments, and emergency departments are required to "leave-behind" naloxone and information with every person who overdosed or is at risk of overdosing.
Since 2017, the number of California state fatalities attributable to synthetic opioids has increased by 1,027%. Fentanyl has been to blame for 20% of deaths among California's teenagers and young adults. California is taking legal efforts to tackle the opioid issue, including patrols, assistance grants, and education.
In response to the surging opioid prescription rates by health care providers that contributed to the opioid epidemic in the United States, US states began passing legislation to stifle high-risk prescribing practices. These new laws fell primarily into one of the following four categories: